1. The basic situation of the meeting
(1) Number of shareholders meeting
This meeting is the third extraordinary general meeting of shareholders in 2021.

(2) Convener
The convener of this general meeting of shareholders is the board of directors.

(3) The legality and compliance of the meeting
The convening and time, method, convener and moderator of this general meeting of shareholders are in compliance with the "Company Law of the People's Republic of China", "Articles of Association of Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd." and "Rules of Procedures for the General Meeting of Shareholders" and other relevant laws and regulations Regulation.

(4) Method of convening the meeting
The meeting method is as follows:
To
none

(5) Date and time of the meeting
1. On-site meeting time: 13:30 on December 1, 2021.

(6) Attendance
1. Shareholders who hold the company's shares on the date of equity registration.
All shareholders of the company registered with ChinaClear at the end of the afternoon on the equity registration day (see the table below for details) are entitled to attend the general meeting (investors who bought securities on the equity registration day have this right, and sold on the equity registration day Securities investors do not have this right), shareholders can appoint an agent in writing to attend the meeting and vote, and the shareholder agent does not have to be a shareholder of the company. Among them, it does not include preference shareholders, and does not include preference shareholders whose voting rights have been restored.

2. Directors, supervisors, senior managers and persons in charge of information disclosure affairs of the company.
(7) Meeting place
VIP Conference Room, 15th Floor, Block C, Lane 58, Xinjian East Road, Minhang District, Shanghai

2. Matters considered at the meeting
(1) Review the "Proposal on the Nomination of the Company's Core Employees"
The report has been disclosed in the "Announcement on Publicizing the Proposed Core Employees and Asking for Comments" (Announcement No.: 2021-039) published on the Information Disclosure Platform of the National Small and Medium-sized Enterprise Share Transfer System (www.neeq.com.cn)

(2) Review the "Proposal on the Company's 2021 Restricted Stock Incentive Plan (Draft)"
The report has been disclosed in the "2021 Restricted Stock Incentive Plan (Draft)" (Announcement No.: 2021-040) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn)

(3) Deliberation on the "Proposal on Requesting the General Meeting of Shareholders to Authorize the Board of Directors to Fully Manage Matters Related to the Restricted Stock Incentive Plan for 2021"
In order to implement the company's equity incentive plan, in accordance with the "Articles of Association" and other relevant regulations, the company's board of directors has asked the shareholders meeting to authorize the board of directors to handle matters related to the restricted stock incentive plan in 2021.

(4) Review the "Proposal on the List of Incentive Objects of the Company's 2021 Restricted Stock Incentive Plan"
The report has been disclosed in the "List of Incentive Objects Granted by the Restricted Stock Incentive Plan for 2021" (Announcement No.: 2021-041) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn)

(5) Deliberation on the "Proposal on Formulating the Implementation Evaluation and Management Measures for the 2021 Restricted Stock Incentive Plan"
The report has been disclosed in the "Administrative Measures for the Implementation Evaluation of Restricted Stock Incentive Plans for 2021" (Announcement No.: 2021-042) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn)

There is a special resolution proposal for the above proposal, and the number of the proposal is (2);
There is no cumulative voting proposal for the above proposal;
There is no separate vote counting proposal for small and medium investors in the above proposal;
There is no resolution of related shareholders' withdrawal form for the above-mentioned proposal;
There is no proposal in which preferred shareholders participate in voting on the above proposal;
There is no proposal to consider public offering of shares and listing on the Beijing Stock Exchange.
3. Conference registration method
(1) Registration method
Shareholders attending the meeting shall register with the following documents: natural person shareholders shall hold their own ID cards; if an agent represents individual shareholders to attend this meeting, they shall present the ID card (copy) of the entrusting person and the authorized entrustment signed by the entrusting person The legal person shareholder shall present his ID card and the legal representative’s identity certificate when attending this meeting; if the legal person shareholder entrusts a representative to attend this meeting, he shall present his ID card and stamp The official seal of the unit and a written power of attorney signed by the legal representative; shareholders can register by letter, fax and door-to-door registration. The company does not accept registration by telephone.

(2) Registration time: 10:30 to 11:30 on December 1, 2021

(3) Place of registration: VIP meeting room on the 15th floor, Block C, Lane 58, Xinjian East Road, Minhang District, Shanghai

Four, other
(1) Conference contact information: 1. Contact address: 15th Floor, Block C, Lane 58, Xinjian East Road, Minhang District, Shanghai 2. Secretary of the Board: Zhang Wei 3. Telephone: 021-54173706 4. Email: dsh2@yananpharm.com

(2) Conference fee: at your own expense

5. List of available documents
Resolutions of the eighteenth meeting of the second board of directors of Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.

Board of Directors of Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.
November 16, 2021